KWM
GILD icon

Keebeck Wealth Management’s Gilead Sciences GILD Stock Holding History

Keebeck Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$583K Buy
4,185
+893
+27% +$125K 0.07% 212
2025
Q4 		$404K Buy
3,292
+154
+5% +$18.7K 0.05% 255
2025
Q3 		$348K Buy
3,138
+196
+7% +$22.3K 0.04% 280
2025
Q2 		$326K Buy
2,942
+114
+4% +$12.1K 0.04% 272
2025
Q1 		$317K Buy
2,828
+340
+14% +$35.1K 0.05% 209
2024
Q4 		$230K Buy
+2,488
New +$224K 0.03% 254
2024
Q1 		– Sell
-2,770
Closed -$224K – 282
2023
Q4 		$224K Buy
+2,770
New +$216K 0.04% 250
2023
Q1 		– Sell
-2,368
Closed -$203K – 253
2022
Q4 		$203K Buy
+2,368
New +$188K 0.04% 231
2020
Q4 		– Sell
-3,416
Closed -$215K – 206
2020
Q3 		$215K Buy
3,416
+1,023
+43% +$70.9K 0.04% 175
2020
Q2 		$184K Buy
+2,393
New +$183K 0.06% 158
2020
Q1 		– Sell
-2,375
Closed -$154K – 219
2019
Q4 		$154K Buy
+2,375
New +$155K 0.05% 157

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Keebeck Wealth Management's GILD Position: Q1 2026 in Review

Keebeck Wealth Management increased its Gilead Sciences (GILD) stake by 27% in Q1 2026, buying an estimated $125K and bringing the position to 4,185 shares worth $583K. The position accounts for 0.07% of the portfolio, ranked #212.

Keebeck Wealth Management first reported a position in GILD in Q4 2019 and has held it in 11 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Keebeck Wealth Management held 4,185 shares of Gilead Sciences worth $583K as of Q1 2026.
  • Keebeck Wealth Management bought 893 Gilead Sciences shares in Q1 2026, an estimated $125K.
  • Gilead Sciences made up 0.07% of Keebeck Wealth Management's portfolio in Q1 2026, its #212 holding.
  • Keebeck Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 11 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Keebeck Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.